Cytokinetics (CYTK) Short-term Investments (2016 - 2024)
Historic Short-term Investments for Cytokinetics (CYTK) over the last 15 years, with Q3 2024 value amounting to $964.8 million.
- Cytokinetics' Short-term Investments rose 11949.96% to $964.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $964.8 million, marking a year-over-year increase of 11949.96%. This contributed to the annual value of $501.8 million for FY2023, which is 3001.35% down from last year.
- According to the latest figures from Q3 2024, Cytokinetics' Short-term Investments is $964.8 million, which was up 11949.96% from $866.6 million recorded in Q2 2024.
- Cytokinetics' 5-year Short-term Investments high stood at $964.8 million for Q3 2024, and its period low was $151.9 million during Q2 2020.
- For the 5-year period, Cytokinetics' Short-term Investments averaged around $481.5 million, with its median value being $492.4 million (2022).
- As far as peak fluctuations go, Cytokinetics' Short-term Investments soared by 12288.83% in 2021, and later tumbled by 4227.32% in 2023.
- Cytokinetics' Short-term Investments (Quarter) stood at $381.1 million in 2020, then decreased by 5.8% to $359.0 million in 2021, then skyrocketed by 99.74% to $717.0 million in 2022, then tumbled by 30.01% to $501.8 million in 2023, then soared by 92.27% to $964.8 million in 2024.
- Its last three reported values are $964.8 million in Q3 2024, $866.6 million for Q2 2024, and $499.0 million during Q1 2024.